Single customs clearance and the non-extendable 150-calendar-day validity

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The easiest trap in the special import authorisation is not the documents but its boundaries in space and time. Article 75 of Acuerdo No. 0631-ARSA-2023, in its final paragraph on Disposiciones finales sobre autorizaciones sanitarias, gives 5 points, and point 1 is the hardest: a special import authorisation must be applied for separately for each import, is valid for a single customs clearance (desaduanaje) only, has a validity of 150 calendar days from the date of issue, and is non-extendable. The other four points: non-commercial storage premises must still meet the sanitary requirements guaranteeing safety, quality and effectiveness; products entering under a special authorisation are subject to inspection and supervision during and after customs clearance; ARSA may at any time require additional documents it considers necessary; and documents from abroad that are not in Spanish must be translated into Spanish. Read the processing clock together with item DÉCIMO TERCERO of Acuerdo No. 012-2020: the deadline runs from the day the application documents are complete, and where a correction is required, from the day the correction is completed.

2. Legal basis

The spatial and temporal limits of the special import authorisation come from the final paragraph of Article 75 of the regulation, while the timing mechanics come from the fee instrument. The table below consolidates the five points and the clock rules.

LevelInstrumentProvisionKey point
RegulationAcuerdo No. 0631-ARSA-2023Article 75, final paragraph, point 1Application per import; valid for a single clearance; 150 calendar days from issue, non-extendable
RegulationAcuerdo No. 0631-ARSA-2023Article 75, final paragraph, point 2Non-commercial storage premises must still meet sanitary requirements
RegulationAcuerdo No. 0631-ARSA-2023Article 75, final paragraph, point 3Inspection and supervision during and after customs clearance
RegulationAcuerdo No. 0631-ARSA-2023Article 75, final paragraph, point 4ARSA may require additional documents it considers necessary
RegulationAcuerdo No. 0631-ARSA-2023Article 75, final paragraph, point 5Foreign documents not in Spanish must be translated into Spanish
FeesAcuerdo No. 012-2020 (La Gaceta No. 35,299, 2020-06-30)Item DÉCIMO TERCEROThe deadline runs from when the dossier is complete; where a correction is required, from completion of the correction
FeesAcuerdo No. 012-2020Item DÉCIMO PRIMEROInstitutional corrections discovered by the applicant before the decision notice are handled by ARSA within the original deadline at no charge
FeesAcuerdo No. 012-2020Item DÉCIMO SEGUNDOAn applicant requesting a shorter deadline must apply for a change of time and pay the fee difference

3. Expert insights

Insight 1: a single clearance is a quantity constraint, not a time constraint. Point 1 confines the effect of the authorisation to one único desaduanaje. The practical meaning is direct: if one shipment arrives on two flights, there are two clearances and two authorisations are needed; one authorisation cannot be stretched to cover multiple arrival batches.

Insight 2: 150 calendar days, non-extendable, is the only benchmark for back-planning logistics. The text reads ciento cincuenta (150) días calendario improrrogable, using calendar days rather than working days and stating expressly that no extension is possible. Production planning must be reverse-engineered from the date of issue: manufacturing, international transport, arrival and clearance must all fit inside the 150 days, with no fallback route of applying for an extension.

Insight 3: a correction resets the clock, the most underestimated risk. Item DÉCIMO TERCERO of Acuerdo 012-2020 provides that the deadline runs from the date the application contains all technical and legal elements, and where a correction is required, from the date of completion of the correction. Document quality therefore directly determines the cycle: an application with a missing item can turn 5 working days (AENG, item SÉPTIMO) into several weeks.

Insight 4: institutional corrections are free, a rule that can be used proactively. Item DÉCIMO PRIMERO provides that institutional corrections (correcciones institucionales) discovered by the applicant before receiving the decision notice are handled by ARSA within the original deadline and free of charge. This differs from the refusal situations of Article 87 or the sale prohibitions of Article 38; it is an error-correction window at the acceptance stage, and GRZAN proactively re-checks ARSA’s keyed-in data after filing.

Insight 5: non-commercial does not mean unregulated. Points 2 and 3 of the final paragraph make clear that non-commercial storage premises must still meet sanitary requirements and that the products remain subject to inspection and supervision during and after clearance. The special authorisation exempts the registration step, not the state of being supervised.

4. Practical recommendations

  • Back-plan applications by arrival batch: one authorisation per clearance; file separately for each arrival batch and do not consolidate the declaration.
  • Make the 150 calendar days a master project milestone: back-plan production, shipment, arrival and clearance from the date of issue, leaving no margin that depends on an extension.
  • Run a full completeness self-check before filing to minimise the risk of a correction, since a correction restarts the processing deadline.
  • After receiving the acceptance receipt, proactively verify the entity, product name and quantity data keyed in by ARSA; request a free institutional correction before the decision notice (item DÉCIMO PRIMERO of Acuerdo 012-2020).
  • Submit Spanish translations of non-Spanish documents together with the application (point 5 of the final paragraph); do not wait for the correction notice.
  • Where acceleration is genuinely needed, apply in writing for a shorter deadline and pay the difference under item DÉCIMO SEGUNDO of Acuerdo 012-2020, rather than chasing verbally.

5. Verification checklist

  • □ Arrival batches have been counted and the number of authorisations matches the number of clearances one to one
  • □ A back-plan against the 150 calendar days exists and contains no assumption of extension
  • □ Application documents have passed a completeness self-check against the 9 items of Article 75
  • □ Spanish translations accompany all non-Spanish documents
  • □ Storage premises meet the sanitary conditions for non-commercial storage
  • □ A named person tracks ARSA correction notices and decision progress
  • □ Acceleration needs have been raised under item DÉCIMO SEGUNDO with the fee difference budgeted

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Honduran market. Our team manages Secretariat of Health (SESAL) registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Regulatory information verified as of October 29, 2026.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail